Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.02 and traded as high as $5.34. Mesoblast shares last traded at $5.30, with a volume of 600 shares trading hands.
Mesoblast Stock Down 52.8 %
The company has a fifty day moving average price of $1.52 and a two-hundred day moving average price of $1.03.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Recommended Stories
- Five stocks we like better than Mesoblast
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Trading Stocks: RSI and Why it’s Useful
- How Do Stock Buybacks Affect Shareholders?
- What is a support level?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
